Purchase Order 75N95025P00054
Award Date
12/17/24
Potential Completion Date
12/16/25
Potential Value
$134K
Federal Agency
National Institute on Drug Abuse
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and consumables. The $729,384.93 contract supports the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing instruments, reagents, and bioinformatics products to NIDA. This appears to be a standalone contract award, rather than being associated with a...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Illumina, Inc. The $292,500.00 contract is for the provision of Illumina sequencing systems, reagents, and associated products and services to support genomic sequencing and analysis. Illumina is an experienced provider of sequencing and genomic analysis technologies to federal agencies, having previously supported work at the NIH, Centers for...
This is a firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $82,507.48 contract has no set-aside designation and does not appear to be associated with a larger contracting vehicle. Under this award, Illumina will provide NIDA with various sequencing systems, reagents, consumables, and related services to support genomic research and diagnostics....
The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a firm-fixed-price delivery order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The $451,656.00 contract does not include any set-aside designation. The award supports the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as associated reagents, consumables, sample preparation kits,...
This is a $78,707.44 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract does not have a set-aside designation. Illumina, a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis, is providing various sequencing systems, reagents, consumables, and other support services to NIDA under this award. Illumina has previously received...
This is a $154,713.12 firm fixed price delivery order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The contract is not associated with a set-aside program. Illumina will provide sequencing systems, reagents, and maintenance services to support genomic research and analysis across a range of federal agencies, including the NIH, CDC, USDA, and VA. Illumina has previously been...
This is a firm fixed price delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract, valued at $1,897,352.58, does not have a set-aside designation. Illumina will provide various NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample prep kits, sequencing chips,...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing and genomic analysis instruments and consumables. The award, valued at $12,524.80, is for the delivery of Illumina sequencing systems and related products to support NIDA's research and diagnostics needs. This award is not associated with a set-aside program. Illumina has received multiple...
This is a firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc. for maintenance support services on NIDA's existing Illumina sequencing systems. The contract has a ceiling value of $144,898.72 and an ultimate completion date of December 4, 2017. This purchase order is not associated with a set-aside program. Illumina, a manufacturer of sequencing and analysis products, has...
This is a firm fixed price delivery order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc. for $82,633.96. The contract covers the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, accompanying reagents and consumables, sample prep kits, sequencing chips, support plans, maintenance services, and bioinformatics products. This appears to be a standalone contract award, not associated with a larger...